NX-001
/ NephRx
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
February 25, 2020
Relative Bioavailability of NXP001 Compared to Emend® in Healthy Volunteers
(clinicaltrials.gov)
- P1; N=12; Completed; Sponsor: Nuformix Technologies Limited; Active, not recruiting ➔ Completed
Clinical • Trial completion
March 22, 2019
"Nuformix $NFX Commences NXP001 Clinical Trial https://t.co/dPybh2BJrv"
(@BiotechRadar)
Clinical
March 26, 2019
Relative Bioavailability of NXP001 Compared to Emend® in Healthy Volunteers
(clinicaltrials.gov)
- P1; N=12; Active, not recruiting; Sponsor: Nuformix Technologies Limited
Clinical • New P1 trial
February 27, 2019
"Nuformix $NFX MHRA approval to commence NXP001 Human Pharmacokinetics https://t.co/jLM9COGUT9"
(@BiotechRadar)
PK/PD data
1 to 4
Of
4
Go to page
1